|
|
Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC
Loic Ysebaert
,
Roch Houot
,
Ibrahim Yakoub-Agha
,
Franck Morschhauser
,
Charles Herbaux
et al.
Blood, 2015, 126 (23), pp.3979-3979
Journal articles
hal-01290424v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.
Emilie Reboursiere
,
Fabien Le Bras
,
Charles Herbaux
,
Emmanuel Gyan
,
Aline Clavert
et al.
Journal articles
hal-01475957v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation
Guillaume Manson
,
Jean-Baptiste Mear
,
Charles Herbaux
,
Jean-Marc Schiano
,
Olivier Casasnovas
et al.
Journal articles
hal-02134578v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA)
Guillaume Manson
,
Charles Herbaux
,
Jean Marc Schiano de Colella
,
René-Olivier Casasnovas
,
Aspasia Stamatoullas
et al.
Journal articles
hal-03665134v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma Real World Evidence from the French Early Access Program
Roch Houot
,
Guillaume Manson
,
Jean-Baptiste Mear
,
Charles Herbaux
,
Jean Marc Schiano de Collela
et al.
Journal articles
hal-02076926v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prolonged remissions after anti-PD1 discontinuation in patients with Hodgkin lymphoma
Guillaume Manson
,
Charles Herbaux
,
Pauline Brice
,
Krimo Bouabdallah
,
Aspasia Stamatoullas
et al.
Journal articles
hal-01812478v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma
John Timmerman
,
Charles Herbaux
,
Vincent Ribrag
,
Andrew D. Zelenetz
,
Roch Houot
et al.
Journal articles
hal-02798009v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of anti-PD1 re-treatment in patients with Hodgkin lymphoma who relapsed after anti-PD1 discontinuation
Guillaume Manson
,
Pauline Brice
,
Charles Herbaux
,
Kamal Bouabdallah
,
Chloé Antier
et al.
Journal articles
hal-02485796v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|